Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Vertex Pharmaceuticals (NQ:VRTX)

454.00 -4.05 (-0.88%)
Official Closing Price Updated: 4:15 PM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,200,493
Open 454.62
Bid (Size) 454.50 (40)
Ask (Size) 459.99 (40)
Prev. Close 458.05
Today's Range 452.88 - 461.05
52wk Range 362.50 - 513.98
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Via ACCESS Newswire
News headline image
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
As of March 20, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) has officially transcended its long-held identity as "the cystic fibrosis (CF) company." For over a decade, the Boston-based biotech giant... 
Via Finterra
Topics Intellectual Property

Performance

YTD
+0.4%
+0.4%
1 Month
-3.3%
-3.3%
3 Month
-1.4%
-1.4%
6 Month
+18.5%
+18.5%
1 Year
-9.8%
-9.8%

More News

Read More
News headline image
Is CRISPR Therapeutics Stock a Buy Now? ↗
Via The Motley Fool
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Merges Strong Fundamentals with Bullish Technical Setup ↗
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗
Via Chartmill
News headline image
My Top 3 Drug Stocks for March 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
1 Momentum Stock to Research Further and 2 We Ignore
Via StockStory
News headline image
Is Vertex Pharmaceuticals Heading to $600? ↗
Via The Motley Fool
News headline image
This Stock Just Jumped By 8%: Is It Too Late to Buy? ↗
Via The Motley Fool
News headline image
2 Reasons to Watch VRTX and 1 to Stay Cautious
Via StockStory
Topics Stocks
News headline image
Vertex Pharmaceuticals Surges 8.3% as Renal Breakthrough Sparks Market Rally
Via MarketMinute
Topics Stocks
News headline image
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
Via StockStory
Topics Economy
News headline image
The Great Biotech Divide: Vertex Soars on Multi-Franchise Breakthroughs as Novo Nordisk Stumbles in the Weight-Loss War
Via MarketMinute
News headline image
Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy
Via MarketMinute
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
Top S&P500 movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Turn Green On Iran War De-Escalation Signals: Why NVDA, ORCL, JOBY, VRTX, ZVRA Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Government
News headline image
VRTX Soars In Extended Hours After Experimental Drug Shows Positive Changes In Autoimmune Kidney Disease ↗
Via Stocktwits
News headline image
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Buying This 1 Biotech Stock Now Could Help Make You a Multimillionaire Retiree ↗
Via The Motley Fool
Topics Intellectual Property Retirement
News headline image
Vertex to Participate in Upcoming March Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 454.00
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 03/20/26 04:15 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 117.78B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 118B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.